Teachers Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $1.69M | Buy |
107,067
+45,493
| +74% | +$717K | ﹤0.01% | 2052 |
|
2018
Q4 | $1.24M | Sell |
61,574
-1,328
| -2% | -$26.7K | ﹤0.01% | 2092 |
|
2018
Q3 | $1.56M | Buy |
62,902
+2,741
| +5% | +$68.1K | ﹤0.01% | 2096 |
|
2018
Q2 | $1.65M | Buy |
60,161
+8,789
| +17% | +$241K | ﹤0.01% | 2063 |
|
2018
Q1 | $1.58M | Buy |
51,372
+8,837
| +21% | +$272K | ﹤0.01% | 1972 |
|
2017
Q4 | $1.52M | Buy |
42,535
+1,620
| +4% | +$57.9K | ﹤0.01% | 2020 |
|
2017
Q3 | $1.13M | Buy |
40,915
+33
| +0.1% | +$909 | ﹤0.01% | 2166 |
|
2017
Q2 | $1.08M | Buy |
40,882
+7,184
| +21% | +$190K | ﹤0.01% | 2185 |
|
2017
Q1 | $701K | Sell |
33,698
-24
| -0.1% | -$499 | ﹤0.01% | 2360 |
|
2016
Q4 | $698K | Buy |
33,722
+1,650
| +5% | +$34.2K | ﹤0.01% | 2367 |
|
2016
Q3 | $520K | Hold |
32,072
| – | – | ﹤0.01% | 2448 |
|
2016
Q2 | $436K | Buy |
32,072
+2,322
| +8% | +$31.6K | ﹤0.01% | 2493 |
|
2016
Q1 | $519K | Buy |
29,750
+3,610
| +14% | +$63K | ﹤0.01% | 2322 |
|
2015
Q4 | $893K | Buy |
26,140
+3,243
| +14% | +$111K | ﹤0.01% | 2066 |
|
2015
Q3 | $681K | Hold |
22,897
| – | – | ﹤0.01% | 2205 |
|
2015
Q2 | $732K | Buy |
22,897
+10,902
| +91% | +$349K | ﹤0.01% | 2298 |
|
2015
Q1 | $249K | Buy |
11,995
+1,471
| +14% | +$30.5K | ﹤0.01% | 2797 |
|
2014
Q4 | $178K | Hold |
10,524
| – | – | ﹤0.01% | 2942 |
|
2014
Q3 | $203K | Hold |
10,524
| – | – | ﹤0.01% | 2878 |
|
2014
Q2 | $358K | Sell |
10,524
-156
| -1% | -$5.31K | ﹤0.01% | 2635 |
|
2014
Q1 | $336K | Buy |
+10,680
| New | +$336K | ﹤0.01% | 2608 |
|